Intelligence Platform
Patents
Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10758613
Combination therapies using anti-metabolites and agents that target tumor-associated strom
granted patentUS 10758614
Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
granted patentUS 10736919
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10729725
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10730925
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of
granted patentUS 10722537
Activation of resident memory T cells for cancer immunotherapy
granted patentUS 10722540
Microfluidic device and method for shear stress-induced transformation of cells
granted patentUS 10716809
Methods of producing enriched populations of tumor reactive T cells from peripheral blood
granted patentUS 10702628
Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration
granted patentUS 10696945
Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem ce
granted patentUS 10683354
Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods
granted patentUS 10675307
Compositions comprising perivascular stem cells and nell-1 protein
granted patentUS 10675267
Methods for detection and eradication of myeloid leukemia stem cells
granted patentUS 10655103
Equine progenitor cells
granted patentUS 10633432
VC-CAR molecule and use thereof in removing HIV-1 infected cells
granted patentUS 10633643
Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells
granted patentUS 10633451
Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine
granted patentUS 10611998
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o
granted patentUS 10596275
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to
granted patentUS 10583202
Homologous recombination in multipotent adult progenitor cells
granted patentUS 10583200
Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi
granted patentUS 10578608
Tools to detect, track and target cancer cells in vivo
granted patentUS 10568913
Method for generating mature β-like cells
granted patentUS 10564149
Populations of mesenchymal stem cells that secrete neurotrophic factors
granted